Table 2.
Most common AFHS-classified medications reported: detailed tier specificationa
| Frequency of medications used (N = 24,697 medications) | ||
|---|---|---|
| N | % | |
| 40:12 Electrolyte Replacement Preparations | 1624 | 6.6 |
| 24:06.08 HMG-CoA Reductase Inhibitors | 1384 | 5.6 |
| 88:16 Vitamin D | 1377 | 5.6 |
| 88:28 Multivitamin Preparations | 1298 | 5.3 |
| 28:08.04.24 Salicylates | 1293 | 5.2 |
| 88:08 Vitamin B Complex | 789 | 3.2 |
| 24:24 beta-Adrenergic Blocking Agents | 733 | 3.0 |
| 68:04 Adrenals | 670 | 2.7 |
| 56:28.36 Proton-pump Inhibitors | 647 | 2.6 |
| 24:32.04 Angiotensin-Converting Enzyme Inhibitors | 608 | 2.5 |
| 24:06.92 Antilipemic Agents, Miscellaneous | 590 | 2.4 |
| 68:36.04 Thyroid Agents | 519 | 2.1 |
| 40:28.20 Thiazide Diuretics | 516 | 2.1 |
| 28:08.04.92 Other Nonsteroidal Anti-inflammatory Agents | 498 | 2.0 |
| 28:16.04.20 Selective Serotonin-reuptake Inhibitors | 380 | 1.5 |
| 52:08 Anti-inflammatory Agents | 354 | 1.4 |
| 28:08.92 Analgesics and Antipyretics, Miscellaneous | 338 | 1.4 |
| 68:20.04 Biguanides | 330 | 1.3 |
| 04:08 Second Generation Antihistamines | 318 | 1.3 |
| 24:32.08 Angiotensin II Receptor Antagonists | 317 | 1.3 |
| 52:08.08 Corticosteroids | 304 | 1.2 |
| 24:28.08 Dihydropyridines | 299 | 1.2 |
| 88:12 Vitamin C | 299 | 1.2 |
| 12:12.08.12 Selective beta-2-Adrenergic Agonists | 291 | 1.2 |
| 28:12.92 Anticonvulsants, Miscellaneous | 241 | 1.0 |
aExcludes non-classified medications; the 25 most commonly reported medications are shown; denominator for percentages is total number of AHFS-classified medications (N = 22,863)